Our analysis of pan-cancer data from TCGA reveals a positive correlation between PRMT3 and PD-L1 expression across various tumor types, suggesting that the PRMT3-lactate-PD-L1 regulatory axis may be a common mechanism in different cancers. The gene discussed is PRMT3; the disease is cancer.